摘要
目的探究胺碘酮在急诊冠心病快速型心律失常患者中的应用效果。方法选取2016年1月~2017年10月我院收治的100例冠心病快速心律失常患者作为研究对象,按照分段随机化法分组,每组各50例。对照组采用常规治疗,实验组采用胺碘酮治疗,对比两组的疗效、不良反应、血压、心率水平以及心电图监测结果。结果实验组冠心病快速心律失常患者的总有效率(96.00%)明显高于对照组的总有效率(74.00%),差异有统计学意义(P<0.05);实验组不良反应发生率明显低于对照组,差异有统计学意义(P<0.05);实验组冠心病快速心律失常患者治疗后的血压、心率水平优于对照组,差异有统计学意义(P<0.05);实验组的心电图检测结果 Q-T间期、P-R间期水平均高于对照组,差异有统计学意义(P<0.05)。结论冠心病快速心律失常患者接受胺碘酮治疗,安全有效,对改善其预后有着积极的意义。
Objective To explore the application effect of Amiodarone in patients with rapid arrhythmia in emergency coronary heart disease（CHD）.Methods A total of 100 CHD patients with tachyarrhythmia who were treated in our hospital from January 2016 to October 2017 were selected as the study subjects.By random section,conventional therapy was used in control group,and Amiodarone was adopted in experimental group.The efficacy,adverse reactions,blood pressure,heart rate levels,and electrocardiograph（ECG） monitoring results were compared between the two groups.Results The total effectiveness rate in the experimental group（96.00%） was significantly higher than that of the control group（74.00%）,the difference was statistically significant（P〈0.05）.The incidence of adverse reactions in the experimental group was lower than that of the control group（P〈0.05）.In the experimental group,after therapy,the levels of blood pressure and heart rate were superior to those in the control group（P〈0.05）.In the experimental group,the test results during Q-T interval and P-R interval by ECG were higher than those of the control group,the differences were statistically significant（P〈0.05）.Conclusion Patients with tachyarrhythmia in CHD undergoing amiodarone treatment are safe and effective,which has positive significance for improving their prognosis.
作者
朱明真
朱凌华
董玉梅
胡文川
ZHU Ming-zhen;ZHU Ling-hua;DONG Yu-mei;HU Wen-chuan(Cardiac Center,Qingdao Fuwai Hospital in Shandong Province,Qingdao 266000,Chin)
出处
《中国当代医药》
2018年第22期70-72,共3页
China Modern Medicine
关键词
胺碘酮
冠心病
快速心律失常
急诊
Amiodarone
Coronary heart disease
Tachyan＇hythmia
Emergency
